SHENZHEN, China--(BUSINESS WIRE)--Tongjitang Chinese Medicines Company (NYSE: TCM), a leading specialty pharmaceutical company focusing on the development, manufacturing, marketing and selling of modernized traditional Chinese medicine in China, today commented on its employee share incentive plan. The Company recently filed a Form S-8 with the U.S. Securities and Exchange Commission to register the ordinary shares issued or issuable under the Company’s 2006 Share Incentive Plan.
